These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1807791)
1. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Fertin C; Nicolas JF; Gillery P; Kalis B; Banchereau J; Maquart FX Cell Mol Biol; 1991; 37(8):823-9. PubMed ID: 1807791 [TBL] [Abstract][Full Text] [Related]
2. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts. Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700 [TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Yamamoto T; Eckes B; Krieg T Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980 [TBL] [Abstract][Full Text] [Related]
4. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. Tiggelman AM; Boers W; Linthorst C; Sala M; Chamuleau RA J Hepatol; 1995 Sep; 23(3):307-17. PubMed ID: 8550995 [TBL] [Abstract][Full Text] [Related]
5. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT. Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444 [TBL] [Abstract][Full Text] [Related]
6. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. Vuorio T; Kähäri VM; Black C; Vuorio E J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219 [TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479 [TBL] [Abstract][Full Text] [Related]
8. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442 [TBL] [Abstract][Full Text] [Related]
9. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma]. Gillery P; Maquart FX; Kalis B; Borel JP C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006 [TBL] [Abstract][Full Text] [Related]
10. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. McWhirter A; Colosetti P; Rubin K; Miyazono K; Black C Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970 [TBL] [Abstract][Full Text] [Related]
11. Connective tissue metabolism including cytokines in scleroderma. Smith EA Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283 [TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma. Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S Br J Dermatol; 2012 Nov; 167(5):1098-105. PubMed ID: 22591006 [TBL] [Abstract][Full Text] [Related]
13. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060 [TBL] [Abstract][Full Text] [Related]
15. Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblasts. Perlish JS; Bashey RI; Stephens RE; Fleischmajer R Arthritis Rheum; 1976; 19(5):891-901. PubMed ID: 962971 [TBL] [Abstract][Full Text] [Related]
16. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196 [TBL] [Abstract][Full Text] [Related]
17. Collagen accumulation by dermal fibroblast cultures of patients with linear localized scleroderma. Buckingham RB; Prince RK; Rodnan GP; Barnes EL J Rheumatol; 1980; 7(2):130-42. PubMed ID: 7373615 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. Oriente A; Fedarko NS; Pacocha SE; Huang SK; Lichtenstein LM; Essayan DM J Pharmacol Exp Ther; 2000 Mar; 292(3):988-94. PubMed ID: 10688614 [TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573 [TBL] [Abstract][Full Text] [Related]
20. Collagen in the extracellular matrix of cultured scleroderma skin fibroblasts: changes related to ascorbic acid-treatment. Heino J; Kähäri VM; Jaakkola S; Peltonen J Matrix; 1989 Jan; 9(1):34-9. PubMed ID: 2710030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]